Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 c
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed account of your organization's significant operational and capital expenditures necessary for the execution of your climate change mitigation transition plan, as outlined in Disclosure Requirement E1-1. This should include an explanation and quantification of investments and funding, referencing the key performance indicators of taxonomy-aligned capital expenditures, and, where applicable, the capital expenditure plans disclosed in accordance with Commission Delegated Regulation (EU) 2021/2178.
-
Question Id: E1-1_04
The financial resources required for the implementation of the decarbonisation levers and their relation to the financial statements are yet to be determined, as this depends on further defining the decarbonisation levers and their mitigation actions.
Report Date: 4Q2024Relevance: 30%
- Provide a detailed account of the reporting boundaries considered and the calculation methods employed for estimating Scope 3 greenhouse gas (GHG) emissions. Specify the calculation tools utilized, if any, for each significant Scope 3 GHG category, ensuring consistency with the Greenhouse Gas Protocol (GHGP) guidelines.
-
Question Id: E1-6_29
Demant employs two different methodologies for scope 3 accounting: one tailored for the Diagnostics business area and another for the Hearing Aids and Hearing Care business areas. Both methodologies align with the scope 3 GHG Protocol standard and follow a combined approach, using hybrid- and spend-based methods for the GHG emissions calculations.
Report Date: 4Q2024Relevance: 60%